POVAN Drug Patent Profile
Which patents cover Povan, and what generic alternatives are available?
Povan is a drug marketed by Parke Davis and is included in two NDAs.
The generic ingredient in POVAN is pyrvinium pamoate. There is one drug master file entry for this compound. Additional details are available on the pyrvinium pamoate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for POVAN?
- What are the global sales for POVAN?
- What is Average Wholesale Price for POVAN?
Summary for POVAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Patent Applications: | 2,389 |
| DailyMed Link: | POVAN at DailyMed |
US Patents and Regulatory Information for POVAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | POVAN | pyrvinium pamoate | SUSPENSION;ORAL | 011964-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parke Davis | POVAN | pyrvinium pamoate | TABLET;ORAL | 012485-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
